VIM and ovarian serous carcinoma: Another study assessed the protein expression of E-CADH, N-CADH, P-cadherin, ZEB1, HMGA2, RAB25, CD24, NCAM, SOX11, and VIM in 100 tubo-ovarian serous carcinoma effusions and found a limited prognostic role of the markers alone or in combination [36].